A systematic review with meta-analysis of studies comparing response to experimentally-evoked pain between obese and non-obese individuals by Astita, R et al.
Send Orders for Reprints to reprints@benthamscience.ae
The Open Pain Journal, 2018, 11, 1-11 1
1876-3863/18 2018  Bentham Open
The Open Pain Journal
Content list available at: www.benthamopen.com/TOPAINJ/
DOI: 10.2174/1876386301811010001
SYSTEMATIC REVIEW
A  Systematic  Review  with  Meta-analysis  of  Studies  Comparing
Response  to  Experimentally-evoked  Pain  Between  Obese  and  Non-
Obese  Individuals
Rehab Astita1,3, Osama A. Tashani1,*, Carole A. Paley1,2, Duncan Sharp1 and Mark I. Johnson1
1Centre for Pain Research, School of Clinical and Applied Sciences, Leeds Beckett University, City Campus, Leeds LS1
3HE, United Kingdom
2Airedale NHS Foundation Trust, Keighley, West Yorkshire BD20 6TD, UK
3Higher Institute of Medical Professions, Al-Bayda, Libya
Received: February 15, 2018 Revised: April 24, 2018 Accepted: May 26, 2018
Abstract:
Background:
The relationship between obesity and pain remains unclear. The aim of this systematic review was to determine whether response to
experimentally-evoked pain differed between obese and non-obese individuals. Studies that compared responses to experimentally-
evoked pain between obese and non-obese human participants post-puberty (i.e. >16 years) were sought. Eligible studies published
between January 1950 and May 2017 were identified by searching OVID, MEDLINE, EMBASE and Science Direct.
Explanation:
Methodological quality of included studies was assessed using the ‘QualSyst’ questionnaire. Of 1106 references identified only nine
studies (683 participants) were eligible for review. Pressure pain was assessed in five studies and electrical pain in three studies. Two
studies investigated thermal pain. Obesity was categorized according to body mass index (BMI) or as weight as a percentage of ideal
body weight. Six of the nine included studies were of low methodological quality. There was a lack of extractable data to pool for
meta-analysis of studies using thermal or electrical pain. A forest plot of data extracted from four studies on pressure pain threshold
found no differences between obese and non-obese groups (overall effect size was Z=0.57, p=0.57).
Conclusion:
Small sample size was the main limitation in all studies. Participants with obesity were more sensitive to mechanical noxious stimuli
than non-obese participants in three of five studies. However, overall, it was not possible to determine whether there are differences
in pain sensitivity response to experimental stimuli between obese and non-obese individuals.
Keywords: Pain, Pain threshold, Pain sensitivity, Obesity, Body fat, BMI.
1. INTRODUCTION
Obesity and chronic pain are global public health problems [1, 2]. Evidence suggests that individuals who are obese
are  more  likely  to  report  chronic  musculoskeletal  pain  [3  -  5]  including  fibromyalgia  [6],  low  back  pain  [7],  and
osteoarthritis [8]. It has been claimed that pain is mediated in part by excess load causing stress on weight bearing joints
leading to potential tissue damage [9, 10], although mechanisms other than mechanical overloading are likely to be
involved because increased pain occurs in both weight bearing and non-weight bearing parts of the body.
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Recently,  attention  has  focussed  on  systemic  inflammation  associated  with  central  obesity  and  whether  this
influences pain [11, 12]. Individuals with central obesity have a propensity for systemic inflammation resulting in body
tissue that  is  swollen and sensitive  to  stimuli  with  the  potential  to  produce pain  [5,  13].  The excessive  visceral  fat
associated  with  central  obesity  contributes  to  an  increase  in  circulating  levels  of  pro-inflammatory  markers  (e.g.
prostaglandins,  C-reactive  protein  and  cytokines  such  as  interleukins  (Interleukin-6),  tumour  necrosis  factor  alpha
(TNF-alpha)  and  leptin)  and  decreased  levels  of  anti-inflammatory  markers  (e.g.  adiponectin).  Pro-inflammatory
markers sensitise nociceptors in peripheral tissue lowering their thresholds of activation (peripheral sensitisation) and
amplifying peripheral nociceptive activity. This sensitises central nociceptive transmission cells (central sensitisation)
resulting in increased pain [14]. However, the relationship between central obesity, systemic inflammation and pain
remains unclear. An epidemiological study investigated the association between obesity and pain prevalence among
older adults in 407 elderly individuals and found that central obesity had the strongest independent association with
pain, although the relationship was not explained by markers of inflammation or insulin resistance [15].
Psychophysical methods can be used to quantify pain by measuring and individual’s response to noxious stimuli
(i.e. experimentally-evoked pain). Common measures include pain threshold, the magnitude of a stimulus necessary to
evoke  the  first  sensation  of  pain,  and  pain  tolerance,  the  magnitude  of  a  stimulus  necessary  to  evoke  pain  that  an
individual can no longer endure. Pain threshold and pain tolerance decrease in the presence of systemic inflammation
[16, 17]. The aim of this systematic review was to determine whether response to experimentally-evoked pain differed
between obese and non-obese individuals.
2. METHODS
2.1. Data Sources and Search Methods for Identification of Studies
This review used the guidelines for Preferred Reporting Items for Systematic Reviews (PRISMA) [18].  Studies
published between January 1950 and May 2017 were identified by searching OVID, MEDLINE, EMBASE and Science
Direct using the following keywords and MeSH terms: [pain sensitivity OR experimental pain OR pain measurement
OR quantitative sensory testing OR pressure pain thresholds OR heat pain thresholds] AND [obesity OR overweight
OR BMI]. We also searched manually for relevant studies in the reference list of hey articles.
2.2. Criteria for Considering Studies for this Review
Studies were included if they:
used healthy human participants post puberty (i.e.>16 years);
measured  response  to  experimentally-evoked  pain  (e.g.  pain  threshold,  pain  tolerance,  pain  intensity  or
unpleasantness rating);
compared obese and non-obese participants by measuring body mass index (BMI, e.g. weight and height) and/or
aspects  of  body  fat  (e.g.  percentage  body  fat)  by  skin  fold  thickness,  waist-hip  ratio  or  dual-energy  X-ray
absorptiometry (DXA) and;
were written in any language with non-English reports translated if necessary.
Studies were excluded if they involved a treatment intervention.
2.3. Study Selection
Two  reviewers  (RA,  OAT)  screened  titles  and  abstracts  independently  to  identify  potentially  relevant  studies.
Reviewers were not blind to the names, institution, journal, or study results. Full reports of potentially relevant studies
were obtained and screened for inclusion by RA and OAT. Disagreements were resolved by consensus with the whole
review team with MIJ acting as arbiter.
2.4. Data Extraction
Data was extracted from included studies by RA and OAT independently including number of participants, age and
gender, measurements to categorise individuals into groups (e.g. non-obese and obese), experimental pain technique
(e.g. noxious stimuli) and pain outcome measures. Agreement between the two reviewers was tested and reported.
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2.5. Assessment of Study Methodology, Outcome and Heterogeneity
The methodological quality of the included studies was assessed independently by two reviewers (RA, OAT) using
11 criteria  developed by Kmet et  al.  [19].  The assessment criteria  of  the quality of  the research were based on the
following questions:
Was the research question/objective sufficiently described?1.
Was the study design evident and appropriate?2.
Was the method of participant/comparison group selection or source of information/input variables described3.
and appropriate?
Were participant and comparison group, (if applicable), characteristics sufficiently described?4.
Was  the  outcome  and,  (if  applicable),  exposure  measure(s)  well  defined  and  robust  to5.
measurement/misclassification bias?
Were means of assessment reported?6.
Was the sample size appropriate?7.
Were the analytical methods described/justified and appropriate?8.
Was some estimate of variance reported for the main results?9.
Was there any control for confounding factors? Was there sufficient detail in the reporting of results?10.
Did the results support the conclusion?11.
It was planned that quantitative data for outcomes would be pooled where possible. In addition, the standardised
mean difference between obese and non-obese participants with 95% CI (continuous data) or relative risk (dichotomous
data) would be calculated. It was also planned that heterogeneity between comparable studies would be assessed, using
Review  Manager  (RevMan)  [Computer  program],  Version  5.3.  (Copenhagen:  The  Nordic  Cochrane  Centre,  The
Cochrane Collaboration, 2014). A tally of outcomes was planned based on at least one statistically significant difference
between groups at any time point if it was not possible to pool data.
Fig. (1). PRISMA flow chart for process of identifying eligible studies.
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3. RESULTS
There were 1099 references identified in the literature search of which 217 were duplicates (Fig. 1). An additional
seven references were identified through manual searches of reviews and discussion articles retrieved from the original
search. This produced 889 references for screening through titles and abstracts. Of these, 872 references were excluded
because they were  either  not  relevant  or  were  studies  that  had been conducted on animals  or  individuals  with  pre-
existing pain conditions (i.e. clinical pain). The full reports of 15 potential studies were assessed for eligibility and eight
of these were excluded (Table 1).
Table 1. Excluded studies with reasons.
Reference Author, Year Reason for Exclusion
[17] (Benson, et al. 2012) No attempt was made to categorise the sample into obese and non-obese by measuring BMI or body fat
[20] (Eberle, et al. 2010) No attempt was made to categorise the sample into obese and non-obese by measuring BMI or body fat
[21] (Euteneuer, et al. 2011)
The study involved patients and control groups. No attempt was made to categorise healthy participants control
into obese and non-obese according to BMI or body fat
[22] (Manson, 2010) Discussion article
[23] (Tashani. et al. 2010) All participants were normal BMI (i.e. not obese)
[24] (Price, et al. 2013) Healthy participants received a placebo intervention as part of a randomised controlled clinical trial
3.1. Characteristics of Included Studies
Nine studies (683 participants) were included for review Table 2a. Five of these studies were conducted before the
year 2000. All reports were written in English language. Study sample size varied between 38 and 206, and age varied
between 16 and 84 years. Three studies used only females [25 - 27] and six studies recruited males and females. Obesity
was categorized according to BMI [27, 28, 29, 30] or actual weight as a percentage of ideal body weight [31] or other
weight measures. Only one study measured body fat directly using dual-energy X-ray absorptiometry (DXA) although
participants were categorised according to BMI [29].
Table 2a. Characteristics of included studies investigating pressure pain.
Study
Study
Participants
[Sample size
(M/F; age)]
Classification
of Obesity
Noxious
Stimuli
Outcome
Measure
Data Obese
[Mean+SD]
Data Non-Obese
[Mean+SD]
Difference
P value
Authors’
Conclusion
Methodological
Quality Score
(%)
Reviewers’
Comment
McKendall
and Haier
(1982)
[31]
N = 60(28/32;
20-67 years)
N obese =
26(8/18)
N non-obese =
34(20/14)
Obese >130%
ideal body
weight
Non-obese
<130% ideal
body weight
Constant
blunt
pressure
applied at
3lbs
applied to
finger
using a
“pressure
bearing
device”
Pain
Threshold
59.4+48.15s 95.51+53.36s <0.001 Obese
more
sensitive to
noxious
stimuli than
non-obese
55%
Pain
Tolerance
81.88+56.09s 131.03+ 51.14s <0.01
Raymond
et al.
(1995)
[27]
N = 104(0/104;
19-50 years)
N obese without
binge eating
disorder [non-
BED] = 33(0/33)
N obese with
binge eating
disorder [BED]
= 27(027)
N non-obese
[control] =
44(0/44)
BMI
Blunt
pressure
applied at
64gs-1 to
finger
using an
Ugo
Basile
analgesia
meter
Pain
Threshold
non-BED=
384+24g
BED =453+31g
356+19g [control] 0.38
No
difference
in
sensitivity
to noxious
stimuli
between
obese and
non-obese
individuals
48%
No statistically
significant
correlation
coefficient (r)
between BMI
and pain
threshold or
tolerance
Pain
Tolerance
non-BED
=544+32g
BED=612+42g
552+29g [control] 0.297
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Study
Study
Participants
[Sample size
(M/F; age)]
Classification
of Obesity
Noxious
Stimuli
Outcome
Measure
Data Obese
[Mean+SD]
Data Non-Obese
[Mean+SD]
Difference
P value
Authors’
Conclusion
Methodological
Quality Score
(%)
Reviewers’
Comment
Khimich
(1997)
[32]
N = 206
(114/92;18-84
years)
N obese (stage
II-III) = Not
reported
N overweight
(stage I obese) =
Not reported
N ‘non-
obese’=Not
reported
Used Broca
index [details
not reported]
into
Obese (stage
II-III)
Obese stage I
(overweight)
Normal
Needle
(sharp)
pressure
applied to
the
forearm
Expression
of mild
pain
[assumed
to be pain
threshold]
Expression
of severe
pain
[assumed
to be pain
tolerance]
72.9g [SD not
reported]
Normal = 40.5g
[SD not reported]
Overweight = 57.6g
[SD not reported]
Not
reported
Obese less
sensitive to
noxious
stimuli than
non-obese
21%
Minimal detail
provided in
report
Overweight
measure for
pain tolerance
reported as
91.3g in
Abstract and
91.8g in Results
116.2g [SD not
reported]
Normal = 76.5g
[SD not reported]
Overweight=91.8g
[SD not reported]
Not
reported
Astita et
al. (2015)
[29]
38 adults (18
women) were
grouped as
normal
weight(n=22) or
obese (n=16)
BMI
Somedic
Algometer
applied at
thenar
eminence
Pain
Threshold
340.93±93.58kPa 447.45±203.72kPa 0.039
Obese
more
sensitive to
blunt
pressure
stimuli than
non-obese
73%
Tashani et
al. (2017)
[30]
72 healthy
participants (37
women) divided
into 3 groups
according to
their BMI:
Normal=25
Overweight= 24
Obese= 25
BMI values
were:
Obese=
34.4+3.90
kg/m2
Normal
=22.1+2.04
kg/m2
Somedic
Algometer
applied at
thenar
eminence
Pain
Threshold
620.72+423.81kPa 1154.70+847.18kPa 0.005
Obese
more
sensitive to
blunt
pressure
stimuli than
non-obese
88%
There were five studies that measured response to pain evoked by noxious pressure. Three studies [31, 29, 30] found
that blunt pressure pain threshold was lower in obese participants than non-obese, whereas Raymond et al. [27] found
that there were no statistically significant differences in pain threshold or pain tolerance in obese participants compared
with non-obese. Khmich [32] claimed that expression of mild pain (which we have assumed to be pain threshold) and
severe pain (which we have assumed to be pain tolerance) to pin-prick was higher in obese participants than non-obese
but there was no statistical analysis to support the claim.
Pradalier et al. [33] used percutaneous electrical stimulation of the sural nerve to evoke nociceptive-flexion reflexes
and found that the threshold to elicit the reflex was lower in obese compared with non-obese individuals. They also
found an inverse correlation between percentage of ideal body weight and the threshold of nociceptive reflex. However,
the nociceptive-flexion reflex of the sural nerve is not a measurement of pain threshold nor tolerance so this study was
not selected for further consideration in our review. Nonetheless, it  was interesting that the threshold for the reflex
response was dependent on the amount subcutaneous fat tissue. There were three studies that measured response to pain
evoked by electrical stimuli applied transcutaneously [25, 26, 28]. Zahorska-Markiewicz et al.  [25] found that pain
threshold to an electrical stimulus on the forearm and arm was higher in obese participants compared with non-obese
(effect size=0.61 at the forearm, 0.53 at the arm). The same investigators conducted a similar study to investigate the
relationship between circadian rhythms and electrical pain threshold during weight-reducing treatment and found that
obese  participants  had higher  pain  thresholds  compared with  non-obese  at  baseline  wit  the  effect  size  =  0.53 [26].
Maffiuletti et al. [28] found that there were no significant differences in intensity of pain associated with the ‘highest
tolerated threshold’ of transcutaneous electrical neuromuscular stimulation of the quadriceps between male obese and
non-obese participants and female obese and non-obese participants when analysed separately. However, they did not
report the analysis of obese and non-obese participants when males and females were combined.
Two  studies  found  that  heat  pain  threshold  values  were  higher  in  obese  participants  compared  with  non-obese
individuals [29, 34, 35] (Table 2b),  although the study by Miscio et al.  [34] found that obese individuals are more
sensitive to cold stimuli than non-obese (effect size for index finger=-0.43, and for little finger=-0.35).
(Table 2a) contd.....
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Table 2b. Characteristics of included studies investigating electrical Pain.
Study
Study
Participants
[Sample
size (M/F;
age)]
Classification
of Obesity
Noxious
Stimuli
Outcome
Measure
Data Obese
[Mean+SD]
Data Non-
Obese
[Mean+SD]
Difference
P value
Authors’
Conclusion
Methodological
Quality Score
(%)
Reviewers’
Comment
Zahorska-Markiewicz
et al. (1983) [25]
N = 48(0/48;
16-52 years)
N obese =
20 (0/20)
N non-obese
= 20 (0/20)
N
underweight
= 8(0/8)
Percentage
excess against
ideal body
weight from
Metropolitan
Life
Insurance
Tables
Mean %
excess obese
= 87.9%, non-
obese = 1.6%
and
underweight
= -10.1%
Transcutaneous
electrical
stimulation of
forearm with
amplitude
increasing
from 0-18mA
Pain
Threshold
Forearm =
13.03+3.27mA
Arm =
8.83+4.31mA
Forearm =
7.55+3.76mA
Arm =
5.56+2.32mA
Forearm
[underweight]
=
5.88+3.18mA
Arm
[underweight]
=
6.1+5.34mA
Forearm
<0.001
Arm
P=<0.01
Obese less
sensitive to
noxious
stimuli than
non-obese
32%
Positive
correlation
between pain
threshold and
body weight,
and weight
excess
Zahorska-Markiewicz
et al. (1988) [26]
N = 49(0/49;
24-61 years)
N obese =
35(0/35)
N non-obese
= 14(0/14)
Percentage
excess against
ideal body
weight from
Metropolitan
Life
Insurance
Tables
Mean %
excess obese
= 64.5%, non-
obese = not
reported
Transcutaneous
electrical
stimulation of
forearm with
amplitude
increasing
from
0-20mAmin-1
at various time
points
throughout the
day and over a
4 week weight
reducing
treatment
phase
Pain
Threshold [1st
measure
taken at 7am
pre-treatment]
12.5+4.4mA 7.3+3.8mA <0.001
Obese less
sensitive to
noxious
stimuli than
non-obese
36%
Main focus of
study was to
investigate
relationship
between
circadian
rhythms and
electrical pain
threshold during
weight-reducing
treatment
Maffiuletti et al.
(2011) [28]
N = 67
(34/33)
N obese =
32(M/F not
reported)
N ‘non-
obese’
=35(M/F not
reported)
BMI
Obese
>30kg/m2
Transcutaneous
electrical
stimulation of
quadriceps
muscle to elicit
muscle
contraction
Pain Intensity
(100mm
VAS) of
‘highest
tolerated
threshold’ to
elicit
contraction
M=46+27mm
F=56+26mm
M=43+26mm
F=48+27mm
Not
significantly
different”
[P value not
reported]
No
difference
in
sensitivity
to noxious
stimuli
between
obese and
non-obese
individuals
66%
Conclusion
“Current
tolerance to
motor
stimulation was
reduced in
obese
individuals …
whereas pain
was not
influenced by
gender or
obesity”
3.2. Assessment of Study Methodological Quality
The  two  reviewers  (RA,  OAT)  assigned  identical  total  study  methodological  quality  scores  for  six  of  the  nine
studies. After discussion the consensus between the team was to take the average of the scores for each component of
the  assessment  of  the  remaining  three  studies  where  there  was  a  difference  in  methodological  quality  scoring.  Six
studies scored more than 50% in the quality assessment criteria. Three studies were classified as poor methodological
quality.
3.3. Assessment of Study Outcome and Heterogeneity
It  was  possible  to  pool  data  from  four  of  the  five  studies  that  recorded  pressure  pain  threshold  to  calculate
standardized mean difference (SDM) based on a fixed effects model. There were no statistically significant differences
between obese and non-obese groups in blunt pressure pain threshold (SMD (95% CI) = -0.08 (-0.36 to 0.20), overall
effect size Z = 0.57, p = 0.57, (Fig. 2). There was substantial heterogeneity between the studies with I2 calculated to be
93%.
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It  was  not  possible  to  pool  data  from  the  three  studies  that  used  electrical  stimuli  because  two  measured  pain
threshold and one measured pain intensity. The authors of two of these studies (both from the same investigating team)
concluded that obese individuals were less sensitive to painful stimuli than non-obese individuals [25, 26]. The authors
of the third study concluded that there were no differences in pain intensity [28]. It was not possible to pool data from
thermal stimuli because there were only two studies. The authors of these studies concluded that obese participants were
less sensitive to noxious thermal stimuli [34, 30].
Fig. (2). The forest plot of standardized mean difference of 4 studies investigated pressure pain threshold of obese and non-obese
healthy participants. .
4. DISCUSSION
Nine studies were included in this systematic review but findings were inconsistent and methodological quality of
the  studies  low.  The  meta-analysis  of  four  studies  on  blunt  pressure  pain  threshold  suggested  that  there  were  no
differences  between  obese  and  non-obese  individuals.  Data  from  two  studies  on  heat  pain  indicated  that  obese
individuals were less sensitive to noxious heat stimuli than non-obese individuals. It was noteworthy that six of the nine
included studies were published over 15 years ago, and the influence of confounding variables including gender, age,
comorbidities (e.g. hypertension, diabetes), and socio-economic factors were not assessed. Thus, there is insufficient
high  quality  research  to  determine  with  any  degree  of  confidence  whether  there  are  differences  in  sensitivity  to
experimentally-evoked pain between obese and non-obese individuals.
A secondary analysis of data obtained as part of a double-blind, placebo controlled, cross-over clinical trial that
investigated the efficacy of naltrexone by Price et al. [24] was excluded from this review because we were unable to
obtain the report of the original study. Data used in the secondary analysis was “pertaining to the placebo session”. We
interpreted  this  to  mean  that  data  collected  from  the  placebo  arm  of  the  clinical  trial  was  used  to  compare  pain
sensitivity  between  obese  and  non-obese  individuals.  This  secondary  analysis  by  Price  et  al.  was  not  eligible  for
inclusion  in  our  systematic  review  because  it  involved  a  placebo  intervention  which  we  specified  as  an  exclusion
criterion and no details were provided about the procedures used to administer the placebo intervention. Nonetheless,
this secondary analysis is the most comprehensive analysis of pain sensitivity responses in obese individuals to date.
The  secondary  analysis  found  no  significant  differences  in  pressure  pain  threshold  on  the  thenar  eminence  and
thumbnail. Inclusion of this data in our review would not have altered our conclusion or decision not to pool data for
meta-analysis.
Interestingly, Price et al. [27] found that contact heat pain threshold and contact cold pain threshold was higher in
obese compared with non-obese participants (i.e. lower pain sensitivity) when measured on at the abdomen but not at
the forehead or thenar eminence. These differences correlated with measures of adiposity and the amount of excess
subcutaneous  fat.  Price  et  al.  also  found  that  obese  individuals  had  higher  pressure  pain  threshold  (i.e.  were  less
sensitive) than non-obese individuals suggesting inconsistency with the findings of studies included in our review. This
may be due to variations in the amount of adipose tissue at different body sites [36]. Unfortunately, Price et al. did not
measure  pressure  pain  threshold  over  the  abdomen.  Price  et  al.  [24]  suggested  that  local  mechanical  and  chemical
factors played a role in the observation of differences in pain thresholds at different body sites and that generalized
factors such as systemic inflammation leading to changes in centralized pain processing were less likely to be involved
(Table 2c). They suggested that localised reductions in sensitivity to noxious thermal stimuli may be due to stretching
of the skin due to excess fat and that this decreased the density of epidermal nerve fibres associated with cold detection
and heat pain (A-delta fibres) and warm detection, heat pain and cold pain (C-fibres).
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Table 2c. Characteristics of included studies investigating thermal Pain.
Study
Study
Participants
[Sample size
(M/F; age)]
Classification of
Obesity
Noxious
Stimuli
Outcome
Measure
Data Obese
[Mean+SD]
Data Non-
Obese
[Mean+SD]
Difference
P value
Authors’
Conclusion
Methodological
Quality Score
(%)
Miscio
et al.
(2005)
[34]
21 obese
non-diabetic
volunteers
versus 20
non-obese
healthy
volunteers
BMI
Obese >30kg/m2
A
computerized
quantitative
device
(Medoc Ltd;
TSA II-2001)
was used to
test the
thresholds for
heat and cold-
evoked pain
(HP-CP)
Cold Pain
on index
finger
12.8+10.2oC 20.5+5.1oC 0.004
Obese
higher heat
pain
threshold
and lower
cold pain
threshold
than non-
obese
72%
Heat Pain
on index
finger
46.4+3.6oC 42.6+3.6oC 0.002
Cold Pain
on little
finger
13.1+10.1oC 19.3+6.0oC 0.021
Heat Pain
on little
finger
46.2+3.9oC 43.3+3.5oC 0.016
Tashani
et al.
(2017)
[30]
74 healthy
participants
(37 women)
divided into 3
groups
according to
their BMI:
Normal=25
Overweight=
24
Obese= 25
BMI values were:
Obese=34.4+3.90kg/m2
Normal=22.1+2.04kg/m2
A
computerized
quantitative
device
(Medoc Ltd;
TSA II-2001)
was used to
test the
thresholds for
heat-evoked
pain threshold
and tolerance
Heat Pain
Threshold
at thenar
eminence
42.29+3.4oC 42.75+3.5oC 0.26
No
differences
between
groups
88%
Heat Pain
Tolerance
at thenar
eminence
48.33+2.61oC 48.23+2.1oC 0.59
Heat Pain
Threshold
at the
waist
41.38+3.07oC 41.39+3.07oC 0.9
Heat Pain
Tolerance
at the
waist
46.71+1.77oC 47.35+1.6oC 0.18
In contrast, other research suggests that the pro-inflammatory state observed in individuals with obesity has been
attributed to the ratio of circulating pro-inflammatory: anti-inflammatory cytokines mediated by visceral fat adipose
cells and leading to alterations in pain sensitivity response. It is not known whether the local adipose tissue environment
is more abundant in, and thus prone to be affected by, anti-inflammatory cytokines whereas the systemic circulatory
environment is more abundant in pro-inflammatory cytokines. Clearly, there is a need for further research to determine
whether changes in pain sensitivity are a generalised phenomenon regardless of body location tested, perhaps mediated
by changes in centralised pain processing, or whether changes are localised, reflecting differences in fat at various body
sites. Moreover, studies included in our review did not measure cytokines and other substances (such as leptin) that are
known to influence nociceptor sensitivity.
One limitation of this systematic review was that the evidence synthesis was based on a low number of studies and
some of these studies where published before recent development in technologies and methodologies to assess pain
sensitivity response. The studies included in our review were vulnerable to high risk of bias including failure to blind
investigators from group identity. We excluded studies measuring pain sensitivity in individuals with a pre-existing pain
condition because it would have increased heterogeneity of the sample populations and further complicated the analysis
of findings.
What can be learned from this systematic review findings is that to design a new study to investigate the differences
between obese and non-obese individuals certain conditions have to be met:
Use of a better obesity indicator than BMI as BMI is a crude categorization of obesity and can be misleading in
judging  obesity  of  some  sub-population  (e.g.  athletes).  There  are  much  better  methods  in  categorization  of
obesity including measure of total body fat.
Data provided in this systematic review should be used to calculate the appropriate sample size of participants to
achieve sufficient statistical power to reach clinical meaningful differences.
Standardised pain induction techniques including Quantitative Sensory Testing should be used in future studies.
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CONCLUSION
It  was not  possible  to  determine whether  there  are  differences in  pain sensitivity  between obese and non-obese
individuals because there were too few studies and those that exist were contradictory and had low methodological
quality ratings. Study designs varied considerably with marked differences in the type of evoking-stimuli used and body
sites tested. Concentrations of pro-inflammatory and anti-inflammatory mediators were rarely measured. There is a
need  for  studies  that  measure  pain  sensitivity  at  different  body  sites  that  assess  body-fat  distribution  and  measure
systemic markers of inflammation.
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